CRP and type 1 diabetes mellitus: Considering the elevated inflammation in T1D and the role these markers have in activating CRP and subsequently increasing the risk of complications, research continues to explore anti-inflammatory therapies, including dietary supplementation, adjuvant therapies, and eating styles [19,20,21,22,23].